Hematology/Oncology

Top Story

Smartphone app helps patients with cancer manage pain

November 13, 2018
Meeting News

Adverse effects from certain immunotherapies may be more common than initially reported

November 13, 2018
Adverse events associated with immune checkpoint inhibitors may be more common than reported in trials that led to FDA approvals of those agents, according to a study…
Meeting News

CheckMate-040: Opdivo may present an option for Child-Pugh B HCC

November 13, 2018
SAN FRANCISCO — Patients with advanced hepatocellular carcinoma with Child-Pugh B status experienced encouraging efficacy and safety outcomes after treatment with…
FDA News

FDA grants priority review to Tecentriq combination for advanced triple-negative breast cancer

November 13, 2018
The FDA granted priority review to a supplemental biologics license application that seeks approval of atezolizumab in combination with nab-paclitaxel for first-line…
In the Journals

Computer tool increases safe outpatient management of pulmonary embolism

November 13, 2018
An internet-based clinical decision support system allowed physicians to quickly and easily identify patients with pulmonary embolism eligible for home treatment without…
More Headlines »
CME ABIM MOC

Ace the Case: A 33-Year-Old Woman with a Mass in Her Right Breast

There is no commercial support for this activity.

This educational activity will utilize a case study to discuss the diagnosis and management of a breast mass in a…
More »
Video
Meeting News

VIDEO: Integrity chief among characteristics for succession in physician leadership

August 16, 2018
More »
Resource Centers
European Society for Medical Oncology Congress

European Society for Medical Oncology Congress

CME CNE CPE

Exploring New Immune Checkpoint Inhibitor Paradigms in Advanced Melanoma

This activity is supported by an educational grant from Bristol-Myers Squibb.

The integration of immune checkpoint inhibitors into treatment algorithms for the management of advanced genitourinary…
More »
Current Issues
View the Current Issue
HemOnc Today